PL2663318T3 - Kompozycja farmaceutyczna do leczenia raka - Google Patents

Kompozycja farmaceutyczna do leczenia raka

Info

Publication number
PL2663318T3
PL2663318T3 PL12702318T PL12702318T PL2663318T3 PL 2663318 T3 PL2663318 T3 PL 2663318T3 PL 12702318 T PL12702318 T PL 12702318T PL 12702318 T PL12702318 T PL 12702318T PL 2663318 T3 PL2663318 T3 PL 2663318T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
treating cancer
cancer
treating
pharmaceutical
Prior art date
Application number
PL12702318T
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Indravadan Ambalal Modi
Original Assignee
Cadila Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Pharmaceuticals Ltd filed Critical Cadila Pharmaceuticals Ltd
Publication of PL2663318T3 publication Critical patent/PL2663318T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12702318T 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka PL2663318T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN92MU2011 2011-01-11
PCT/IB2012/050120 WO2012095789A1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer
EP12702318.2A EP2663318B1 (en) 2011-01-11 2012-01-10 Pharmaceutical composition for treating cancer

Publications (1)

Publication Number Publication Date
PL2663318T3 true PL2663318T3 (pl) 2015-08-31

Family

ID=54264167

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12702318T PL2663318T3 (pl) 2011-01-11 2012-01-10 Kompozycja farmaceutyczna do leczenia raka

Country Status (10)

Country Link
US (2) US20130295648A1 (pl)
EP (1) EP2663318B1 (pl)
JP (1) JP5889335B2 (pl)
CN (1) CN103338779B (pl)
AU (1) AU2012206322B2 (pl)
CA (1) CA2824417C (pl)
ES (1) ES2536842T3 (pl)
PL (1) PL2663318T3 (pl)
RU (1) RU2580888C2 (pl)
WO (1) WO2012095789A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2663318T3 (pl) * 2011-01-11 2015-08-31 Cadila Pharmaceuticals Ltd Kompozycja farmaceutyczna do leczenia raka
JP6421208B2 (ja) * 2017-02-28 2018-11-07 カディラ ファーマシューティカルズ リミテッド がん抗原
JP2024513966A (ja) * 2021-04-12 2024-03-27 ランタン ファルマ インコーポレイテッド 肺がん及び非小細胞肺がんを処置する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
CN100572540C (zh) * 2002-04-16 2009-12-23 成都永安制药有限公司 包括表达丙氨酸脱氢酶、丝氨酸脱水酶和/或谷氨酰胺合成酶的重组卡介苗菌株的结核病疫苗
US20100086911A1 (en) * 2005-03-03 2010-04-08 Ryosuke Katsuyama Preventive/therapeutic agent for cancer
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
PL2663318T3 (pl) * 2011-01-11 2015-08-31 Cadila Pharmaceuticals Ltd Kompozycja farmaceutyczna do leczenia raka
ES2647768T3 (es) * 2011-07-05 2017-12-26 Cadila Pharmaceuticals Limited Antígeno de cáncer

Also Published As

Publication number Publication date
AU2012206322B2 (en) 2016-09-01
EP2663318B1 (en) 2015-03-18
CA2824417A1 (en) 2012-07-19
CN103338779B (zh) 2015-12-23
WO2012095789A1 (en) 2012-07-19
US9415078B2 (en) 2016-08-16
US20150290255A1 (en) 2015-10-15
JP5889335B2 (ja) 2016-03-22
AU2012206322A1 (en) 2013-08-29
CN103338779A (zh) 2013-10-02
CA2824417C (en) 2019-02-26
RU2580888C2 (ru) 2016-04-10
JP2014502631A (ja) 2014-02-03
RU2013136780A (ru) 2015-02-20
EP2663318A1 (en) 2013-11-20
US20130295648A1 (en) 2013-11-07
ES2536842T3 (es) 2015-05-29

Similar Documents

Publication Publication Date Title
PT2818482T (pt) Composição farmacêutica para o tratamento de cancro
PL2824114T3 (pl) Kompozycja farmaceutyczna do leczenia nowotworu
AP3864A (en) Pharmaceutical composition
IL227429A0 (en) The components and methods of cancer treatment
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
IL234831A0 (en) Medical preparations for combined treatment
GB201118232D0 (en) Pharmaceutical composition
IL228644A0 (en) Cancer treatment methods
ZA201308157B (en) Pharmaceutical composition
EP2774917A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
HRP20160851T1 (hr) Prediktori za liječenje karcinoma
LT2814473T (lt) Farmacinės kompozicijos, skirtos derinių terapijai
ZA201503005B (en) Ingenol-derived compounds useful for treating cancer
SG11201400976WA (en) Methods and pharmaceutical compositions for treating cancer
IL229231A0 (en) Preparations and methods for the treatment of cancer
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
EP2663318A1 (en) Pharmaceutical composition for treating cancer
IL232479A0 (en) Combined treatment of ovarian cancer
SI2617412T1 (sl) Sestavek za topično zdravljenje
HUP1100444A2 (en) Pharmaceutical composition
HUP1100445A2 (en) Pharmaceutical composition
EP2785343A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA
SG10201601715YA (en) Novel Pharmaceutical Combinations And Methods For Treating Cancer
IL213610A0 (en) Composition for treating dermatological conditions